drugset / Trial / NCT00501111
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with mild or moderate Alzheimer's disease, to assess the safety and tolerability of ZAD3480 and to define the optimal dose(s) to be used in future trials.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | — | Oral |
| Subject | ispronicline | Small molecule | — | Oral |